Vimarsana
Biggest News Aggregation in the World

Donna Lessard News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Donna Lessard. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Donna Lessard Today - Breaking & Trending Today

Héma-Québec appeals to public for donations of type O blood - Vimarsana News

Héma-Québec appeals to public for donations of type O blood

The need for type O blood has increased over the past few days.

Year-round gratitude: It changes lives, one meal, one step, one kindness at a time - Vimarsana News

Year-round gratitude: It changes lives, one meal, one step, one kindness at a time

Volunteers with the Central Brevard Sharing Center and the Under the Bridge ministry show their gratitude for life's gifts by serving others

Source: yahoo.com
U.S. company that made deal to produce COVID vaccine in Canada warns it could go out of business - Vimarsana News

U.S. company that made deal to produce COVID vaccine in Canada warns it could go out of business

Novavax executives told investors that there is uncertainty surrounding the company's ability to fund operations as the COVID-19 vaccine market changes

Japanese chemical company to close Quebec COVID-19 vaccine manufacturer Medicago | iNFOnews - Vimarsana News

Japanese chemical company to close Quebec COVID-19 vaccine manufacturer Medicago | iNFOnews

MONTREAL - The Quebec government says it's looking to find a buyer for Medicago Inc., the Quebec-based COVID-19 vaccine manufacturer that will be shut down by parent company Mitsubishi Chemical.

Source: infotel.ca
'Planning for dropouts': Drugmakers grapple with testing unproven vaccines on seniors - Vimarsana News

'Planning for dropouts': Drugmakers grapple with testing unproven vaccines on seniors

  TORONTO -- At age 70, retired nurse Donna Lessard can expect to be towards the front of the line for a COVID-19 vaccine when supply and distribution expands in coming months. But instead, she's opted for an unproven vaccine candidate she can have now -- a two-dose product by the Quebec City-based biopharmaceutical Medicago currently running Phase 2 clinical trials. Because the trials are blinded, the Montrealer doesn't know if last month she received a second dose of the prospective vaccine or a placebo, and may not know for a year -- well after most Canadians are expected to receive o...

Source: ctvnews.ca